Saskia van de Ven

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Wendy Onstenk, Jaco Kraan, Bianca Mostert et al. · Molecular Cancer Therapeutics · 2014 · 58 citations · Full text

Breast Oncology, Pathology, Cancer Biology +20

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

Ayoub Charehbili, Saskia van de Ven, Vincent T.H.B.M. Smit et al. · Annals of Oncology · 2014 · 38 citations · Full text

Zoledronic Acid, Breast Oncology, Medicine +7

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Stefanie de Groot, Ayoub Charehbili, Hanneke W.M. van Laarhoven et al. · Breast Cancer Research · 2016 · 36 citations · Full text

Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort

Saskia van de Ven, H.J.G.D. van den Bongard, Bart J. Pielkenrood et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 31 citations · Full text

Patient-reported Outcomes, Radiation Therapy, Medicine +7

Judging Amy: Automated legal assessment using OWL 2

Saskia van de Ven, Rinke Hoekstra, Joost Breuker et al. · Data Archiving and Networked Services (DANS) · 2008 · 26 citations · Full text